5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole

Yoshihiko Maehara, Yoshihisa Sakaguchi, Ikuo Takahashi, Motofumi Yoshida, Hiroki Kusumoto, Hidetaka Masuda, Keizo Sugimachi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We obtained evidence that the cytotoxic effect of 5-fluorouracil (5-FU) is augmented when the drug is given in combination with hyperthermia (HYP) and dipyridamole (DP). Nontoxic levels of DP enhanced the combined cytotoxicity of 5-FU and HYP against B16 melanoma and human tumor cells in vitro as measured by the succinate dehydrogenase inhibition (SDI) test. Growth of B16 melanoma that had been subcutaneously implanted into the feet of C57 BL mice was inhibited by treatment with the combinations of 5-FU and HYP, of 5-FU and DP, and of 5-FU, HYP and DP as compared with the administration of 5-FU alone. Treatment with HYP plus DP did not alter the body weight of mice that received 5-FU. The administration of DP plus HYP seemed to render the tumor cells more sensitive to 5-FU. The combination of 5-FU, HYP and DP shows promise for the treatment of patients suffering from malignant disease.

Original languageEnglish
Pages (from-to)257-260
Number of pages4
JournalCancer chemotherapy and pharmacology
Volume29
Issue number4
DOIs
Publication statusPublished - Jul 1 1992

Fingerprint

Dipyridamole
Cytotoxicity
Fluorouracil
Fever
Experimental Melanomas
Therapeutics
Tumors
Cells
In Vitro Techniques
Succinate Dehydrogenase
Foot
Neoplasms
Body Weight

All Science Journal Classification (ASJC) codes

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Cite this

5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole. / Maehara, Yoshihiko; Sakaguchi, Yoshihisa; Takahashi, Ikuo; Yoshida, Motofumi; Kusumoto, Hiroki; Masuda, Hidetaka; Sugimachi, Keizo.

In: Cancer chemotherapy and pharmacology, Vol. 29, No. 4, 01.07.1992, p. 257-260.

Research output: Contribution to journalArticle

Maehara, Yoshihiko ; Sakaguchi, Yoshihisa ; Takahashi, Ikuo ; Yoshida, Motofumi ; Kusumoto, Hiroki ; Masuda, Hidetaka ; Sugimachi, Keizo. / 5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole. In: Cancer chemotherapy and pharmacology. 1992 ; Vol. 29, No. 4. pp. 257-260.
@article{8e1818adbd9948e0b65337cd106aaf3d,
title = "5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole",
abstract = "We obtained evidence that the cytotoxic effect of 5-fluorouracil (5-FU) is augmented when the drug is given in combination with hyperthermia (HYP) and dipyridamole (DP). Nontoxic levels of DP enhanced the combined cytotoxicity of 5-FU and HYP against B16 melanoma and human tumor cells in vitro as measured by the succinate dehydrogenase inhibition (SDI) test. Growth of B16 melanoma that had been subcutaneously implanted into the feet of C57 BL mice was inhibited by treatment with the combinations of 5-FU and HYP, of 5-FU and DP, and of 5-FU, HYP and DP as compared with the administration of 5-FU alone. Treatment with HYP plus DP did not alter the body weight of mice that received 5-FU. The administration of DP plus HYP seemed to render the tumor cells more sensitive to 5-FU. The combination of 5-FU, HYP and DP shows promise for the treatment of patients suffering from malignant disease.",
author = "Yoshihiko Maehara and Yoshihisa Sakaguchi and Ikuo Takahashi and Motofumi Yoshida and Hiroki Kusumoto and Hidetaka Masuda and Keizo Sugimachi",
year = "1992",
month = "7",
day = "1",
doi = "10.1007/BF00685941",
language = "English",
volume = "29",
pages = "257--260",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - 5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole

AU - Maehara, Yoshihiko

AU - Sakaguchi, Yoshihisa

AU - Takahashi, Ikuo

AU - Yoshida, Motofumi

AU - Kusumoto, Hiroki

AU - Masuda, Hidetaka

AU - Sugimachi, Keizo

PY - 1992/7/1

Y1 - 1992/7/1

N2 - We obtained evidence that the cytotoxic effect of 5-fluorouracil (5-FU) is augmented when the drug is given in combination with hyperthermia (HYP) and dipyridamole (DP). Nontoxic levels of DP enhanced the combined cytotoxicity of 5-FU and HYP against B16 melanoma and human tumor cells in vitro as measured by the succinate dehydrogenase inhibition (SDI) test. Growth of B16 melanoma that had been subcutaneously implanted into the feet of C57 BL mice was inhibited by treatment with the combinations of 5-FU and HYP, of 5-FU and DP, and of 5-FU, HYP and DP as compared with the administration of 5-FU alone. Treatment with HYP plus DP did not alter the body weight of mice that received 5-FU. The administration of DP plus HYP seemed to render the tumor cells more sensitive to 5-FU. The combination of 5-FU, HYP and DP shows promise for the treatment of patients suffering from malignant disease.

AB - We obtained evidence that the cytotoxic effect of 5-fluorouracil (5-FU) is augmented when the drug is given in combination with hyperthermia (HYP) and dipyridamole (DP). Nontoxic levels of DP enhanced the combined cytotoxicity of 5-FU and HYP against B16 melanoma and human tumor cells in vitro as measured by the succinate dehydrogenase inhibition (SDI) test. Growth of B16 melanoma that had been subcutaneously implanted into the feet of C57 BL mice was inhibited by treatment with the combinations of 5-FU and HYP, of 5-FU and DP, and of 5-FU, HYP and DP as compared with the administration of 5-FU alone. Treatment with HYP plus DP did not alter the body weight of mice that received 5-FU. The administration of DP plus HYP seemed to render the tumor cells more sensitive to 5-FU. The combination of 5-FU, HYP and DP shows promise for the treatment of patients suffering from malignant disease.

UR - http://www.scopus.com/inward/record.url?scp=0026601225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026601225&partnerID=8YFLogxK

U2 - 10.1007/BF00685941

DO - 10.1007/BF00685941

M3 - Article

C2 - 1537070

AN - SCOPUS:0026601225

VL - 29

SP - 257

EP - 260

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 4

ER -